ISL
IMGN

Ingalls & Snyder LLC’s Immunogen Inc IMGN Stock Holding History

Ingalls & Snyder LLC’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,200
Closed -$185K – 360
2013
Q2 		$185K Buy
+11,200
New +$185K 0.01% 329